Clinical Trials Open for Enrollment as of Nov 2009

Oncology Trials

MMConnect- an observational study for people with newly diagnosed Multiple Myeloma.

LORHAN- an observational study for newly diagnosed head/neck cancer patients receiving chemotherapy and/or radiation treatment.

PNH registry- an observational study for any patient diagnosed with PNH – does not have to be newly diagnosed.

Avida Study- an observational study for patients receiving Vidaza treatment for the first time.

These oncology studies will open shortly

L- Fortis- A phase 3, randomized, double-blind, placebo-controlled study of oral talactoferrin in addition to best supportive care in patients with non-small cell lung cancer who have failed two or more prior treatment regimens.

Panorama MM study- A phase 3 randomized, double-blind, placebo controlled study of panobinostat in combination with bortezomib and dexamethasone in patients with relapsed multiple myeloma.

MCL study – A randomized phase 4 study comparing two intravenous temsirolimus regimens in subjects with relapsed, refractory, mantle cell lymphoma

Infectous Disease Trials

POEM study- an observational study for HIV patients who are eligible to be on the drug, Maraviroc.

Cubist registry- a yearly data collection study of 21 patients receiving the drug Daptomycin.